Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: BAX

Baxter International Inc.

Healthcare | Medical - Instruments & Supplies

Market prices for BAX are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-2.09

Baxter International Inc. (NYSE: BAX) is a medical instruments and supplies company. Figures from SEC EDGAR; updated 2026-10-20 00:22 UTC.

What Baxter International Inc. does

Baxter International manufactures and sells essential healthcare products including sterile intravenous solutions, infusion systems, parenteral nutrition therapies, injectable pharmaceuticals, surgical products, smart bed systems, patient monitoring technologies, and respiratory devices. The company distributes these products globally to hospitals, nursing homes, surgery centers, dialysis facilities, and patients at home under physician supervision. Baxter operates manufacturing facilities across multiple countries and sells its products worldwide.

Summarized from Baxter International Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-2.09
Debt/equity1.55

Revenue, margins & earnings

FY2021 Net income: $1.28BFY2021 Operating expenses: $3.37BFY2021 Cost of revenue: $7.43B$12.1BFY2021FY2022: net loss $2.43B on revenue $10.1B$10.1BFY2022FY2023 Revenue: $10.4B — margin split not shown (non-operating gains)$10.4BFY2023FY2024: net loss $649M on revenue $10.6B$10.6BFY2024FY2025: net loss $957M on revenue $11.2B$11.2BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-03
  • 2026-09-03President and CEOTax withholding-54,276$1.39M
  • 2026-09-03President, Front Line CareTax withholding-2,098$53.9K
  • 2026-09-03President, CCSTax withholding-750$19.1K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Baxter International Inc. do?

Baxter International manufactures and sells essential healthcare products including sterile intravenous solutions, infusion systems, parenteral nutrition therapies, injectable pharmaceuticals, surgical products, smart bed systems, patient monitoring technologies, and respiratory devices.

When did BAX last file with the SEC?

Baxter International Inc.'s most recent SEC filing on record is a 8-K filed 2026-08-19. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 00:22 UTC. This page is also available as JSON at /api/data?ticker=BAX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for BAX and 5,000+ tickers.

Create a free account — keep BAX
For your agent
GET /api/data?ticker=BAX

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt